Group 1 - The Hang Seng Index (HSI) is currently showing weak signals, with a potential drop to support levels around 22,855 points and a lower Bollinger Band at 22,900 points [1] - Investors are considering entering the market at 23,000 points, with a focus on bear certificates with a recovery price of 23,865 HKD [1] Group 2 - Tencent Holdings (00700) is experiencing a bearish trend, with a technical signal indicating "sell." The stock price is currently above the lower Bollinger Band but has dipped below it during the day [3] - Key levels to watch include the middle Bollinger Band at 490 HKD; if it fails to hold, further declines may occur [3] Group 3 - Meituan-W (03690) is also showing a "sell" signal, with potential support levels at 121.9 HKD and 114.5 HKD, close to the lower Bollinger Band at 116.7 HKD [5] - Investors are advised to observe these support levels before considering a rebound at around 120 HKD [5] Group 4 - HSBC Holdings (00005) has shown relatively smaller declines compared to other stocks, but the technical signal remains "sell." The stock is nearing the lower Bollinger Band, indicating a weak trend [8] - The support level to watch is 88.1 HKD, with the middle Bollinger Band at 86.3 HKD [8] Group 5 - BYD (01211) is trading near its support level of 121 HKD, with a bearish signal indicating further potential declines [10] - Key support levels are identified at 119.5 HKD and 112 HKD [10] Group 6 - Semiconductor Manufacturing International Corporation (00981) is also under a "sell" signal, with the stock approaching the lower Bollinger Band [13] - Short-term support levels are at 38.1 HKD and 36.4 HKD, with the weekly Bollinger Band bottom at 36.6 HKD [13]

Market Analysis - The analysis suggests that Bitcoin's recent rally might be short-lived, with potential resistance around 108,000 [1] - The report identifies a bearish divergence in the market, with price failing to make new highs while CVD (Cumulative Volume Delta) does, indicating potential selling pressure [1] - The analysis suggests a possible retracement to test support levels, specifically the support-resistance flip zone, before any further upward movement [1] - The report anticipates a period of consolidation or sideways trading before a potential C wave rally [1] - The analysis points out the similarity between the current market pattern and previous patterns, suggesting a potential dip to liquidate long positions before a new high [2] Technical Indicators - The analysis uses Fibonacci retracement levels (0.618%, 0.66%, 0.786%) to identify potential resistance areas [1] - The report highlights a bearish divergence based on CVD (Cumulative Volume Delta) analysis, signaling potential weakness in the rally [1] - MACD (Moving Average Convergence Divergence) is used to compare current market conditions with historical patterns, identifying potential similarities and future trends [2] - The analysis notes that a large number of long positions (146 million, 18 million, 85 million) may indicate an overbought condition [1] Risk Management - The report advises caution due to potential market volatility and the possibility of unexpected events, such as geopolitical tensions, impacting the market [2] - The analysis emphasizes the importance of having a clear trading plan and adhering to stop-loss orders to manage risk [2]

Core Viewpoint - China Life Insurance (02628.HK) has shown strong technical performance, breaking out of a previous sluggish phase and establishing a mid-term upward trend, with significant trading volume indicating increased investment in the financial insurance sector [1][3]. Technical Analysis - The stock price has surpassed key resistance levels of 16.00 to 16.14 HKD and is approaching a short-term resistance level of 17.10 HKD. A solid hold above this level could pave the way for challenges to previous highs of 19 HKD and even 20.50 HKD [3]. - The technical structure displays a typical W-bottom rebound, supported by ideal trading volume, indicating market consensus on the rebound and suggesting the potential for a new mid-term upward trend [3]. - Technical indicators such as the MACD show a bullish momentum with a golden cross and increasing histogram, while the RSI is above 70, indicating overbought conditions but without clear signs of weakness [3][6]. Market Signals - Currently, the market has set a short-term target price for China Life at 18.42 HKD, suggesting approximately 2.91% upside potential, with mid-term potential to challenge above 20 HKD [6]. - The market sentiment remains highly bullish, with 16 strong buy signals identified, reflecting a strong technical buying consensus [6]. Investment Strategy - Investors are advised to monitor the consolidation platform between 16.10 and 16.30 HKD. If the stock price maintains stability and breaks above 17.20 HKD with increased volume, it will confirm the breakout, allowing for incremental buying with targets set between 19 and 20.50 HKD [9].

Core Viewpoint - Tencent's stock price is currently at 506 HKD, showing a slight decline of 0.78%, with trading volume at 2.854 billion HKD, indicating a cautious market sentiment as the stock hovers below the 10-day moving average [1] Technical Analysis - The stock is experiencing narrow fluctuations below the 10-day moving average of 512.3 HKD, with the MACD indicator signaling a sell but nearing the zero axis, suggesting reduced volatility [1] - Key support is identified at 491 HKD, with potential downside to 474 HKD if this level is breached; resistance is noted at 522 HKD, with a breakthrough potentially leading to a challenge at 539 HKD [1] - Despite multiple moving averages indicating sell signals, the RSI at 52 is in a neutral zone, while the Williams indicator shows an oversold buy signal, reflecting a tug-of-war between bullish and bearish forces [1] Market Instruments - In the current market, bullish options include HSBC call warrant 15418 (16.3x leverage, exercise price 576.38 HKD) and UBS call warrant 17137 (11.6x leverage, exercise price 563.5 HKD), both exhibiting relatively low implied volatility [5] - For bearish strategies, options such as Morgan Stanley put warrant 15137 (10.3x leverage, exercise price 443.33 HKD) and UBS put warrant 16669 (10.7x leverage, exercise price 443.13 HKD) are available, along with Morgan Stanley bear certificate 58426 (16.9x leverage, redemption price 540 HKD) and UBS bear certificate 54414 (13.2x leverage, redemption price 550 HKD) [8]

Cryptocurrency Exchange Platforms & Promotions - Bybit is highlighted as a preferred platform for technical analysis [1] - Binance offers a 40% fee reduction [1] - OKX provides commission waivers [1] - Pionex is recommended for grid trading [1] Cryptocurrency & Blockchain Topics - Mentions of Bitcoin (BTC), Ethereum (ETH), Dogecoin (DOGE), Solana (SOL), Cardano (ADA), Binance Coin (BNB), Ripple (XRP), Polkadot (DOT), Avalanche (AVAX), and Luna/Terra [1] - Discussion of technical analysis concepts including Dow Theory, Elliott Wave Theory, Fibonacci, Harmonic Patterns, and Gann Theory [1] - References to Bitcoin halving in 2024, Bitcoin ETFs, Bitcoin futures, and hardware wallets [1] - Mentions of stablecoins like Tether (USDT) [1] Trading Strategies & Concepts - Discussion of trading strategies such as going long, going short, hedging, and bottom fishing ("抄底") [1] - Mentions of contract trading and margin trading [1] Social Media & Community - Promotion of Discord and Telegram communities for support and announcements [1] - Links to Twitter and a course website [1]

Core Viewpoint - WuXi Biologics (02269) shows strong performance with a stock price of HKD 26.4, up 1.54%, indicating continued capital inflow and strong short-term momentum [1] Technical Analysis - The stock is in a bullish pattern with key resistance at HKD 27.5; a breakthrough could lead to a challenge of HKD 29, while support is at HKD 24.7, presenting a potential buying opportunity [1] - The 10-day, 30-day, and 60-day moving averages are in a bullish arrangement, suggesting a positive medium-term trend [1] - The MACD has shown a golden cross and continues to expand, indicating further upward potential, although the RSI is nearing overbought levels [1] - Current technical signals include 15 buy signals, 6 neutral signals, and 3 sell signals [1] Product Performance - On June 6, 2025, WuXi Biologics' stock rose 7.1% over two days, leading to strong performance in related warrants, with UBS bull certificates (56751) rising 43% and JPMorgan bull certificates (57118) increasing by 38% [3] - For those optimistic about WuXi Biologics breaking through HKD 27.5, low-premium, high-leverage call options are recommended, such as HSBC call option (14447) with a strike price of HKD 29.15 [5] Investment Opportunities - In the bull certificate market, JPMorgan bull certificate (57118) offers a leverage of 4.4 times with a recovery price of HKD 22, while UBS bull certificate (56751) has a recovery price of HKD 22.5 [9] - For bearish strategies, UBS bear certificate (57177) provides 5 times leverage with a recovery price of HKD 30, and Societe Generale bear certificate (58298) also offers 5 times leverage with a recovery price of HKD 30.5 [9]

Core Viewpoint - China National Offshore Oil Corporation (CNOOC) shows a strong bullish trend with stock price steadily approaching resistance levels, reflecting increased market confidence [1][10]. Technical Analysis - CNOOC's stock closed at HKD 18.52, up 1.31%, continuing a stable upward trend, with the price recovering above all major moving averages [1]. - The stock has formed a bullish pattern, with a strong buy signal indicated by various technical indicators, including MACD and ADX [1][10]. - The RSI is at 69, nearing overbought territory, but not yet in extreme conditions, suggesting a healthy upward trend [3]. - The stock's volatility is manageable, with a 5-day amplitude of 3.6%, indicating no significant speculative activity [1]. Market Activity - Trading volume reached HKD 1.128 billion, indicating active market participation supporting the price increase [1]. - CNOOC's related derivatives have outperformed the stock, with notable gains in structured products like the Societe Generale bull certificate and HSBC call warrants [1][6]. Derivative Products - CNOOC's derivatives offer diverse investment options, with UBS and HSBC call warrants providing approximately 10x leverage, making them attractive for bullish strategies [6]. - The Societe Generale bull certificate leads with 7x leverage, offering an efficient tool for bullish investors [6]. Summary - CNOOC exhibits a clear bullish trend supported by healthy trading volume and positive indicator resonance, although caution is advised due to potential overbought signals and divergence risks [10].

Core Viewpoint - China Life Insurance (02628.HK) is experiencing a strong upward trend in its stock price, currently at 17.16 HKD, reflecting a 1.06% increase, following a rebound from a short-term support level of 16.2 HKD [1] Technical Analysis - The stock price has surpassed all major technical moving averages, including the 10-day moving average at 16.4 HKD, the 30-day moving average at 15.63 HKD, and the 60-day moving average at 15.23 HKD, indicating a bullish structure [1] - The stock is approaching the first resistance level at 17.3 HKD, with a potential target of 18.3 HKD if this level is breached [2] - The recent volatility is reflected in a 6.8% fluctuation over five days, with an RSI index at 72, indicating a technical overbought condition [3] - The overall technical indicators are rated as "strong buy," with a signal strength of 16 points, supported by bullish momentum across all categories [3] - The MACD has completed a golden cross and maintains an expanding trend, supporting a continued upward pattern [3] - The price has successfully broken through the Ichimoku cloud, suggesting further upward potential in the coming weeks [3] Derivative Products Performance - On June 6, China Life's related structured products performed well, with a 2.76% increase in the underlying stock, leading to significant gains in derivatives [4] - The Societe Generale bull certificate (53998) led with a 15% increase, outperforming the underlying stock, showcasing the leverage advantage of bull certificates in rising markets [4] Investment Options - Current market conditions provide diverse investment options through China Life's related structured products, with call options offering a leverage of 4.1 times [7] - Bull certificates from HSBC (53706) and JPMorgan (53835) offer over 5 times actual leverage, with a buyback price set at 14 HKD [7] - For bearish strategies, Citigroup's bear certificate (56865) offers a leverage of 4.7 times, with a buyback price set at 20 HKD, providing a favorable risk-reward ratio [7] Summary - China Life is in a healthy upward phase with strong volume-price support and trend indicator resonance, but caution is advised due to potential overbought conditions and divergence risks [10]

Core Viewpoint - Industrial and Commercial Bank of China (ICBC) shows strong bullish signals despite short-term volatility risks, with technical indicators suggesting a potential upward trend in stock price [1][3]. Technical Analysis - Multiple moving averages indicate a strong buy signal, with MA10 at 5.76, MA30 at 5.59, and MA60 at 5.52, while the current price of 5.88 is above these averages, confirming a clear upward trend [3]. - The RSI index is at 69, indicating an overbought condition, while some indicators like the Williams and Stochastic Oscillators signal sell opportunities. However, ADX and psychological indicators remain neutral, and momentum indicators suggest buying [3]. - Key support and resistance levels are crucial for understanding ICBC's price movements, with immediate support at 5.68 and secondary support at 5.48. The first resistance level is at 5.99, and a breakthrough could lead to a challenge at 6.28 [3]. Product Performance - Recent performance of ICBC-related derivatives has been strong, with products like JPMorgan's bull certificates and call options seeing significant gains of 12% and 9% respectively, while the underlying stock rose by 1.03% [5]. Derivative Products - Various options are available for investors, including JPMorgan's call option with a leverage of 9.5 times and an exercise price of 6.67, suitable for aggressive investors [7]. - For more defensive strategies, the Barclays call option offers a leverage of 10.4 times with an exercise price of 6.61, while UBS's bull certificates are recommended for short-term rebounds with a recovery price of 5 [7][8]. - Investors looking to hedge against potential downturns can consider UBS's and JPMorgan's bear certificates, with recovery prices around 6.2-6.3, but should be cautious of the resistance at 6.2 [7].

Core Viewpoint - Tencent is at a critical decision point with its stock price showing mixed signals from various technical indicators, indicating potential volatility in the near term [3][4][5]. Technical Analysis - The stock price is currently fluctuating around 518.5 HKD, with short-term support at 508.21 HKD (MA10) and 502.79 HKD (MA30), while the medium-term support is at 496.57 HKD (MA60) [3]. - Key support levels are identified at 499 HKD and 483 HKD, while resistance levels are at 531 HKD and 547 HKD [4]. - The stock has shown a volatility of 5.4% over five days, with a narrowing Bollinger Band indicating an impending breakout [4]. Short-term Trading Strategy - If the stock price stabilizes above 515 HKD and breaks through 531 HKD, it may trigger a new upward trend, suggesting the use of high-leverage bull certificates or near-price call options [5]. - Conversely, if the price falls below the 499 HKD support, investors should be cautious of potential pullback risks and consider deploying bear certificates or put options for hedging [5]. Performance of Derivative Products - From June 3 to June 5, Tencent's stock rose by 1.98%, positively impacting related derivative products, with UBS bull certificates surging by 33% and HSBC bull certificates increasing by 30% [6]. - Call options from UBS and JPMorgan also saw significant gains of 18% and 11%, respectively, highlighting the leverage effect of these products in a rising market [6]. Recommended Products - Among the current options, UBS call option 17137 offers a leverage of 11.1 times with a strike price of 563.5 HKD, suitable for bullish investors [7]. - For bearish positions, JPMorgan put option 15137 provides a leverage of 9.7 times with a strike price of 443.33 HKD, presenting a low premium for investors anticipating a downturn [7]. Popular Bull and Bear Certificates - HSBC bull certificates 67818 and 67820 offer leverage of 9.5 times and 8.8 times, respectively, with redemption prices set at 465 HKD and 460 HKD [10]. - For bearish strategies, Societe Generale bear certificate 58795 provides a high leverage of 17.8 times with a redemption price of 546 HKD, while JPMorgan bear certificate 58426 offers an even higher leverage of 20.2 times with a redemption price of 540 HKD [10].